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Abstract 
Review on t(9;22)(p13;q13) PAX5/BRD1, with 
data on clinics, and the genes implicated. 
Clinics and pathology 
Disease 
B-cell acute lymphoblastic leukemia (ALL) 
Epidemiology 
Only one case to date, a 2-years old boy wit h a 
CD10+ ALL (Nebral et al., 2009). 
Prognosis 
The patient was considered as at intermediate risk. 
He remains in complete remission 44 months after 
diagnosis. 






391 amino acids; from N-term to C-term, PAX5 
contains: a paired domain (aa: 16-142); an 
octapeptide (aa: 179-186); a partial homeodomain 
(aa: 228-254); a transactivation domain (aa: 304-
359); and an inhibitory domain (aa: 359-391). 
Lineage-specific transcription factor; recognizes the 
concensus recognition sequence 
GNCCANTGAAGCGTGAC, where N is any 
nucleotide. Involved in B-cell differentiation. Entry  
of common lymphoid progenitors into the B cell 
lineage depends on E2A, EBF1, and PAX5; 
activates B-cell specific genes and repress genes 
involved in other lineage commitments. Activates 
the surface cell receptor CD19 and repress FLT3. 
Pax5 physically interacts with the RAG1/RAG2 
complex, and removes the inhibitory signal of the 
lysine-9-methylated histone H3, and induces V-to-
DJ rearrangements. Genes repressed by PAX5 
expression in early B cells are restored in their 
function in mature B cells and plasma cells, and 
PAX5 repressed (Fuxa et al., 2004; Johnson et al., 
2004; Zhang et al., 2006; Cobaleda et al., 2007; 
Medvedovic et al., 2011). 
BRD1 
Protein 
1058 amino acids (aa); from N-term to C-term, 
BRD1 contains a zinc finger PHD-type (aa 214-
264); a bromo domain (aa 579-649) (recognizes 
acetylated lysine residues; prerequisite for protein-
histone association and chromatin remodeling); a 
PWWP domain (aa 929-1012) (conserved Pro-Trp-
Trp-Pro motif; binds histones independently of their 
acetylation, also binds DNA). Phosphoserines are at 
aa 128, 1052, and 1055, and N6-acetyllysine at aa 
368, 516, 519, and 903. BN1 and BN2 (BRPF N-
terminal conserved region 1 and 2) (aa 60-222) is 
the domain binding MOZ/MORF (Ullah et al., 
2008). An enhancer of polycomb homology region 
(EPL1) (EPL1 protein are members of histone 
acetyltransferase complex) , which binds to ING5 
and mediates association with MEAF6, is located 
from amino acids 540 and 640 (Ullah et al., 2008). 
BRD1 is a subunit of the MOZ histone acetyl 
transferase (HAT) complex.  
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PAX5/BRD1 fusion protein. 
 
The MOZ HAT functions is a multi-protein 
complex with BRD1, ING5 (inhibitor of growth 5, 
2q37.3), and MEAF6 (MYST/Esa1-Associated 
Factor 6, 1p34.3).  
BRD1 links the MOZ catalytic subunit to the ING5 
and MEAF6 subunits, and promotes MOZ HAT 
activity.  
The bromodomain of BRD1 acetylates lysine 
residues of histones H3, H4, H2A, and H2B 
(H3K14ac, H4K5ac, H4K8ac, H4K12ac, and 
H2AK5ac). The PWWP domain of BRD1 is the 
binding module for trimethylation of Lys36 of 
histone H3 (H3K36me3) associated with the 
elongation phase of transcription (Vezzoli et al., 
2010).  
There are different splice variants, which are 
induced differentially in different brain regions 
(Fryland et al., 2012).  
The variant BRPF2 may be a negative regulatory 
factor of the variant BRPF1. BRD1 is widely 
expressed in various tissues, the brain in particular 
(in the cell nucleus, perikaryal cytosol and proximal 
dendrites of the neurons), with high expression at 
early embryonic stages (Severinsen et al., 2006; 
Bjarkam et al., 2009).  
BRD1 has a central role during embryonic 
development through Moz-dependent histone 
acetylation, to maintain expression of Hox genes 
(Laue et al., 2008). BRD1 forms a novel HAT 
complex with KAT7 (HBO1, 17q21.33) and is 
required for transcriptional activation of erythroid 
developmental regulator genes (Mishima et al., 
2011). BRD1 showed association with 
schizophrenia and bipolar affective disorder 
susceptibility (Bjarkam et al., 2009). 








1264 amino acids, according to the authors. The 
predicted fusion protein contains the DNA binding 
paired domain and octapeptide of PAX5 (201 aa), 4 
amino acids, and the entire BRD1 (1058 aa). 
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